Research and Development
Biogen Alzheimer’s treatment accepted into EMA’s PRIME scheme
June 2, 2016 Research and Development, Sales and Marketing Alzheimer's, Biogen, EMA, PRIME, accelerated approval
Global oncology market to reach $150 billion by 2020, says IMS Health
June 2, 2016 Research and Development IMS Health, annual global growth, cancer drugs, oncology
Novartis’ Afinitor gets EU approval to treat cancerous gastrointestinal or lung tumors
June 2, 2016 Research and Development, Sales and Marketing Afinitor, Cancer, European Commission, Novartis, regulation
Phase III trials to start in Novartis/Genmab multiple sclerosis collaboration
June 2, 2016 Research and Development Arzerra, Genmab, Novartis, multiple sclerosis, ofatumumab, phase III
Janssen says its Trevicta gets European regulatory approval as maintenance therapy for Schizophrenia
June 2, 2016 Medical Communications, Research and Development European Commission, Janssen, Trevicta, schizophrenia
Nice rejects Janssen’s Imbruvica in draft guidance
June 1, 2016 Medical Communications, Research and Development
Biogen says European regulatory committee adopts positive view for Tysabri
June 1, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, CHMP, EMA, Tysabri, multiple sclerosis
Biomarin withdraws regulatory submissions for Duchenne muscular dystrophy drug
June 1, 2016 Research and Development, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, EMA, FDA, Kyndrisa, failure, rejection
GSK’s gene therapy Strimvelis gets European regulatory nod
June 1, 2016 Research and Development, Sales and Marketing EU, European Commission, GlaxoSmithKline, Strimvelis, gene therapy, regulation
FDA approves Lilly/Boehringer Ingelheim type-2 diabetes drug
June 1, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, diabetes, jentadueto, jentadueto xr, lilly, partnership, type 2, type-2
FDA asks Teva for further study on Huntington drug candidate
June 1, 2016 Medical Communications, Research and Development Huntington disease, Teva, US FDA, regulation
AbbVie, Janssen’s Imbruvica gets European approval to teat CLL
May 31, 2016 Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, CLL, drug trial, regulation
Roche launches Bluetooth-enabled self-testing device to check blood clotting in EU
May 31, 2016 Manufacturing and Production, Research and Development, Sales and Marketing HealthTech, Heart Conditions, Roche, blood clotting, product launch
Weekly Movers: XenoPort, Akari, Bayer…
May 31, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Sarepta Therapeutics, Stick Market, Stock, Xenoport, finance
EU green-lights Samsung Bioepis, Biogen’s Remicade biosimilar Flixabi
May 31, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, Samsung Bioepis, biosimilar, drug trial, regulation, research
